Loading...
Loading...

Turning Up Gene Expression to Treat Disease / Cell, December 7, 2017 (Vol. 171, Issue 7)

Cell Press
Subscribers 11,600
5,332

Report Video

Found this content disturbing or inciting religious hatred ? email us along with this video url.

[email protected]

Embed Video

Published on Dec 11, 2017 at 09:12 pm

In a new study, the therapeutic potential of Cas9-based epigenetic gene activation is explored in mouse models of type I diabetes, acute kidney injury, and muscular dystrophy.

Check out the paper at: http://www.cell.com/cell/fulltext/S0092-8674(17)31247-3.

H.-K. Liao, F. Hatanaka, T. Araoka, P. Reddy, M.-Z. Wu, Y. Sui, T. Yamauchi, M. Sakurai, D. O'Keefe, E. Nunez, et al. (2017). In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation. Cell 171.

And read more great research at http://www.cell.com/cell/home.

Loading...

Sitting Alone ?

... Show More